Results 21 to 30 of about 10,789,024 (363)

Acknowledgement to Reviewers of Journal of Cardiovascular Development and Disease in 2018

Journal of Cardiovascular Development and Disease, 2019
Rigorous peer-review is the corner-stone of high-quality academic publishing[...]
Journal of Cardiovascular Development and Disease Editorial Office
doaj   +1 more source

Luteolin Pretreatment Ameliorates Myocardial Ischemia/Reperfusion Injury by lncRNA-JPX/miR-146b Axis

Analytical Cellular Pathology, 2023
Background. In the present study, we aimed to find out whether luteolin (Lut) pretreatment could ameliorate myocardial ischemia/reperfusion (I/R) injury by regulating the lncRNA just proximal to XIST (JPX)/microRNA-146b (miR-146b) axis. Methods.
Tongda Xu, Yuanyuan Zhang, Gege Liao, Haochen Xuan, Jie Yin, Jieli Bao, Yang Liu, Dongye Li   +7 more
doaj   +1 more source

COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives

Nature Reviews Cardiology, 2020
Coronavirus disease 2019 (COVID-19), caused by a strain of coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic that has affected the lives of billions of individuals.
M. Nishiga, Daowen Wang, Yaling Han, D. Lewis, Joseph C. Wu   +4 more
semanticscholar   +1 more source

Mitochondrial autophagy: molecular mechanisms and implications for cardiovascular disease

Cell Death and Disease, 2022
Mitochondria are highly dynamic organelles that participate in ATP generation and involve calcium homeostasis, oxidative stress response, and apoptosis.
Anqi Li, Meng Gao, Bili Liu, Yuan Qin, Lei Chen, Hanyu Liu, Huayan Wu, Guohua Gong   +7 more
semanticscholar   +1 more source

Orthostatic variation of pulmonary artery pressure in ambulatory heart failure patients

BMC Cardiovascular Disorders, 2023
Aim To study effect of change in position (supine and standing) on pulmonary artery pressure (PAP) in ambulatory heart failure (HF) patients. Methods Seventeen patients with CardioMEMS® sensor and stable heart failure were consented and included in this ...
Prince Sethi, Prakash Acharya, Payton Lancaster, Brianna Stack, Kartik Munshi, Sagar Ranka, Zubair Shah, Andrew J. Sauer, Kamal Gupta   +8 more
doaj   +1 more source

Who Has Seen Patients With ST‐Segment–Elevation Myocardial Infarction? First Results From Italian Real‐World Coronavirus Disease 2019

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background After the coronavirus disease 2019 outbreak, social isolation measures were introduced to contain infection. Although there is currently a slowing down of the infection, a reduction of hospitalizations, especially for myocardial infarction ...
Valeria Cammalleri, Saverio Muscoli, Daniela Benedetto, Giuseppe Stifano, Massimiliano Macrini, Alessio Di Landro, Marco Di Luozzo, Massimo Marchei, Enrica Giuliana Mariano, Linda Cota, Domenico Sergi, Andrea Bezzeccheri, Michela Bonanni, Martino Baluci, Pasquale De Vico, Francesco Romeo   +15 more
doaj   +1 more source

Mitophagy in Cardiovascular Diseases [PDF]

Journal of Clinical Medicine, 2020
Cardiovascular diseases are one of the leading causes of death. Increasing evidence has shown that pharmacological or genetic targeting of mitochondria can ameliorate each stage of these pathologies, which are strongly associated with mitochondrial dysfunction.
Morciano, Giampaolo, Patergnani, Simone, Bonora, Massimo, Pedriali, Gaia, Tarocco, Anna, Bouhamida, Esmaa, Marchi, Saverio, Ancora, Gina, Anania, Gabriele, Wieckowski, Mariusz R, Giorgi, Carlotta, Pinton, Paolo   +11 more
openaire   +4 more sources

Lysophosphatidic Acid Is Associated With Cardiac Dysfunction and Hypertrophy by Suppressing Autophagy via the LPA3/AKT/mTOR Pathway

Frontiers in Physiology, 2018
Background: Lysophosphatidic acid (LPA), as a phospholipid signal molecule, participates in the regulation of various biological functions. Our previous study demonstrated that LPA induces cardiomyocyte hypertrophy in vitro; however, the functional role ...
Jinjing Yang, Jinjing Yang, Jinjing Yang, Jiyao Xu, Jiyao Xu, Xuebin Han, Xuebin Han, Hao Wang, Yuean Zhang, Yuean Zhang, Jin Dong, Jin Dong, Yongzhi Deng, Yongzhi Deng, Jingping Wang, Jingping Wang   +15 more
doaj   +1 more source

European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012)

International Journal of Behavioral Medicine, 2012
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by ...
J. Perk, G. Backer, H. Gohlke, I. Graham, Željko Reiner, W. Verschuren, C. Albus, P. Benlian, G. Boysen, R. Cífková, C. Deaton, S. Ebrahim, Miles Fisher, G. Germano, R. Hobbs, A. Hoes, Ş. Karadeniz, A. Mezzani, E. Prescott, L. Rydén, M. Scherer, M. Syvänne, W. Reimer, C. Vrints, D. Wood, J. Zamorano, F. Zannad, Developed with the special contribution of the European Asso Rehabilitation   +27 more
semanticscholar   +1 more source

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

Nature, 2011
Metabolomics studies hold promise for the discovery of pathways linked to disease processes. Cardiovascular disease (CVD) represents the leading cause of death and morbidity worldwide.
Zeneng Wang, Elizabeth Klipfell, Brian J Bennett, Robert A. Koeth, B. Levison, Brandon Dugar, Ariel E. Feldstein, Earl B. Britt, Xiaoming Fu, Yoon-Mi Chung, Yuping Wu, P. Schauer, Jonathan D. Smith, H. Allayee, W. H. W. Tang, J. DiDonato, A. Lusis, Stanley L. Hazen   +17 more
semanticscholar   +1 more source